# Nektar Therapeutics

Type: Company (NKTR)

Source: Legal & RegTech Intelligence Brief — https://getlegalbrief.com/entity/nektar-therapeutics
Canonical HTML page: https://getlegalbrief.com/entity/nektar-therapeutics

## Timeline

- **2026-03-22**: Enphase Suit Filed — Pomerantz LLP files class action litigation against Enphase Energy in federal court.
- **2026-03-21**: Litigation Launch — Pomerantz LLP officially announces class action litigation against Nektar Therapeutics.
- **2026-03-12**: Nektar Financial Update — Nektar files updated results of operations and financial condition reports.
- **2026-02-10**: Nektar Disclosure — Nektar Therapeutics issues Regulation FD disclosure regarding its business operations.
- **2026-02-03**: Enphase Financials — Enphase Energy files results of operations with the SEC, highlighting market challenges.

## Recent coverage (1 stories)

### Pomerantz LLP Targets Nektar and Enphase in New Securities Class Actions
2026-03-22 02:45:17 · Sentiment: Neutral · Impact: 5/10 · Sources: 3

Pomerantz LLP has initiated class action lawsuits against Nektar Therapeutics and Enphase Energy, alleging violations of federal securities laws. The litigation follows a series of financial disclosures and regulatory filings in early 2026 that triggered significant market volatility for both companies.
Full story: https://getlegalbrief.com/story/pomerantz-llp-nektar-enphase-class-action

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getlegalbrief.com/guides/methodology for the full editorial methodology.